GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Net Policyholder Benefits/Claims

BerGenBio ASA (OSL:BGBIO) Net Policyholder Benefits/Claims


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


BerGenBio ASA Business Description

Industry
Traded in Other Exchanges
Address
Nygardsgaten 114, Bergen, NOR, 5008
BerGenBio ASA is a clinical-stage biopharmaceutical company developing drugs for aggressive diseases, including drug resistant and metastatic cancers and respiratory disease. Its product, bemcentinib (BGB324), is a selective, potent, oral small molecule AXL inhibitor that has been tested in a various indications including NSCLC, AML and severe respiratory infections.